Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 3/2020

01-09-2020 | Macroalbuminuria | Editorial

Diabetic kidney disease and diabetic retinopathy: the ominous duo

Author: Vijay Viswanathan

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2020

Login to get access

Excerpt

Diabetic kidney disease (DKD) and diabetic retinopathy (DR) are two feared complications of diabetes. The article by Dash et al., in this journal, “Diabetic retinopathy and its association with low glomerular filtration rate: a cross sectional analysis of diabetes patients of community clinics across India”, looks at the association between these two microvascular complications [1]. …
Literature
1.
Dash K, Ahmed A, Das S, Jaganmohan B, Tippisetty S, Kolukula VK, et al. Diabetic retinopathy and its association with low glomerular filtration rate: a cross-sectional analysis of diabetes patients of community clinics across India. Int J Diabetes Dev Ctries. 2020. https://​doi.​org/​10.​1007/​s13410-019-00779-2.
2.
3.
Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res. 2012;136(1):46–53.PubMedPubMedCentral
4.
5.
Viswanathan V, Kumpatla S, Tilak P, Kuppusamy A. Relationship between retinal-renal complications among type 2 diabetic subjects in India. Int J Diabetol Vasc Dis Res. 2013;1(2):8–14.
6.
7.
Sabanayagam C, Chee ML, Banu R, et al. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population. JAMA. 2019;2(3):e191540.
8.
Viswanathan V, Krishnamoorthy E, Kumpatla S, et al. Clinical and biochemical characteristics and the association of angiotensin type 1 receptor with normoalbuminuric chronic kidney disease among South Indian Type 2 diabetes population. Int J Diabetes Dev Countries. 2019;39:254–61.CrossRef
9.
Anitharani A and Viswanathan V : Estimated glomerular filtration rate using creatinine based chronic kidney disease epidemiology collaborarion equation. Letter to Editor. Ind J Neprol 2018: 28(6): 492–493.
10.
Kumpatla S, Soni A, Viswanathan V. Comparison of two creatinine based equations for routine estimation of GFR in a speciality clinic for diabetes. J Assoc Physicians India. 2017;65(8):38–41.PubMed
Metadata
Title
Diabetic kidney disease and diabetic retinopathy: the ominous duo
Author
Vijay Viswanathan
Publication date
01-09-2020
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-020-00867-8

Other articles of this Issue 3/2020

International Journal of Diabetes in Developing Countries 3/2020 Go to the issue

Original Article

Care burden and quality of life in mothers of children with type 1 diabetes mellitus

Original Article

BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus

Original article

Beliefs of Caribbean type 2 diabetes patients towards insulin therapy and prescription

Short Article

Management of children and adolescents having type 1 diabetes during COVID-19 pandemic in India: challenges and solutions

Review Article

Diagnosis and principles of management of gestational diabetes mellitus in the prevailing COVID-19 pandemic

Correction

Correction to: RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits